Guinness Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-41,460
Closed -$2.94M 103
2017
Q2
$2.94M Hold
41,460
0.62% 54
2017
Q1
$2.82M Buy
41,460
+7,440
+22% +$523K 0.63% 51
2016
Q4
$2.44M Buy
34,020
+4,170
+14% +$310K 0.59% 52
2016
Q3
$2.36M Buy
29,850
+3,940
+15% +$320K 0.59% 54
2016
Q2
$2.16M Hold
25,910
0.59% 57
2016
Q1
$2.38M Buy
25,910
+5,680
+28% +$512K 0.72% 56
2015
Q4
$2.05M Buy
20,230
+690
+4% +$71.8K 0.84% 54
2015
Q3
$1.92M Buy
19,540
+5,080
+35% +$564K 0.89% 47
2015
Q2
$1.69M Buy
14,460
+40
+0.3% +$4.37K 0.65% 47
2015
Q1
$1.42M Buy
14,420
+5,640
+64% +$573K 0.66% 52
2014
Q4
$828K Buy
+8,780
New +$908K 0.41% 55

Other funds holding GILD

Guinness Asset Management's GILD Position: Q3 2017 in Review

Guinness Asset Management sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 41,460 shares — an estimated $2.94M sold.

Guinness Asset Management first reported a position in GILD in Q4 2014 and held it in 11 quarters. The position peaked at $2.94M in Q2 2017. 1,505 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Guinness Asset Management reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Guinness Asset Management sold 41,460 Gilead Sciences shares in Q3 2017, an estimated $2.94M.
  • Guinness Asset Management first reported a position in Gilead Sciences in Q4 2014 and held it in 11 quarters.
  • Guinness Asset Management's Gilead Sciences position peaked at $2.94M in Q2 2017.
  • 1,505 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Guinness Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.